These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2801617)

  • 1. Heterogeneity of estrogen receptor in primary breast carcinoma evaluated by computed image analysis.
    Simony J; Pujol JL; Grenier J; Pujol H
    Am J Clin Pathol; 1989 Oct; 92(4):559. PubMed ID: 2801617
    [No Abstract]   [Full Text] [Related]  

  • 2. HER2 expression in Brazilian patients with estrogen and progesterone receptor-negative breast carcinoma.
    Ramalho S; Serra KP; Vassallo J; Soares FA; Pinto GA; Teixeira LC; da Cunha IW; Derchain SF; de Souza G
    Acta Histochem; 2013 Mar; 115(2):120-7. PubMed ID: 22647460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oestrogen receptor status of breast carcinoma: Allred/H score conversion table.
    Shousha S
    Histopathology; 2008 Sep; 53(3):346-7. PubMed ID: 18631198
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytochemical detection of estrogen receptors in mammary tumours.
    Gădăleanu V; Gavrilescu TH
    Morphol Embryol (Bucur); 1985; 31(1):31-4. PubMed ID: 3157051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sensitivity and specificity of estrogen receptor, progesterone receptor and HER-2 staining in core biopsies of invasive breast carcinomas.
    Frederik P; Cecile C; Tjalma WA
    Breast J; 2007; 13(4):436-7. PubMed ID: 17593058
    [No Abstract]   [Full Text] [Related]  

  • 6. Aromatization of testosterone and oestrogen receptor levels in human breast cancer.
    Li K; Adams JB
    J Steroid Biochem; 1981 Mar; 14(3):269-72. PubMed ID: 7218792
    [No Abstract]   [Full Text] [Related]  

  • 7. Determination of ploidy and steroid receptor status in breast cancer by laser scanning cytometry.
    Bollmann R; Torka R; Schmitz J; Bollmann M; Méhes G
    Cytometry; 2002 Aug; 50(4):210-5. PubMed ID: 12210600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid hormone receptors and peroxidase activity in human breast cancer.
    Keenan EJ; Garrison LB; Kemp ED; Porter JM; Moseley HS; Fletcher WS
    Surg Forum; 1979; 30():547-9. PubMed ID: 538691
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunocytochemical demonstration and morphometric study by image analysis of estrogen receptors in carcinoma of the breast: study of 30 cases].
    Cohen O; Seigneurin D; Brugal G; Weintraub J; Demongeot J; Mouriquand J; Mouriquand C
    C R Acad Sci III; 1987; 304(14):385-8. PubMed ID: 3109693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commentary on "Application of Photoshop-based Image Analysis to Quantification of Hormone Receptor Expression in Breast Cancer".
    Gown AM
    J Histochem Cytochem; 2022; 70(11-12):767-768. PubMed ID: 36546603
    [No Abstract]   [Full Text] [Related]  

  • 11. The evaluation of estrogen receptor in primary breast carcinoma by computer-assisted image analysis.
    Bacus S; Flowers JL; Press MF; Bacus JW; McCarty KS
    Am J Clin Pathol; 1988 Sep; 90(3):233-9. PubMed ID: 2458030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Image analysis of breast cancer immunohistochemistry-stained sections using ImageJ: an RGB-based model.
    Vrekoussis T; Chaniotis V; Navrozoglou I; Dousias V; Pavlakis K; Stathopoulos EN; Zoras O
    Anticancer Res; 2009 Dec; 29(12):4995-8. PubMed ID: 20044607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unusual triple-negative breast carcinoma.
    Shousha S; Peston D; Gojis O; Palmieri C
    Histopathology; 2009 Sep; 55(3):364-6. PubMed ID: 19723156
    [No Abstract]   [Full Text] [Related]  

  • 14. [Association of HER2 genetic heterogeneity with clinicopathological characteristics in breast cancer].
    Yang YL; Fan Y; Lang RG; Gu F; Fu L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Oct; 27(5):540-5. PubMed ID: 20931533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer outcomes by steroid hormone receptor status assessed visually and by computer image analysis.
    Mohammed ZM; Edwards J; Orange C; Mallon E; Doughty JC; McMillan DC; Going JJ
    Histopathology; 2012 Aug; 61(2):283-92. PubMed ID: 22571413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference in hormone receptor content in breast cancers from Vietnamese and Swedish women.
    Thang VH; Tani E; Johansson H; Adolfsson J; Krawiec K; Van TT; Skoog L
    Acta Oncol; 2011 Apr; 50(3):353-9. PubMed ID: 21395466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential use of spectral image analysis for the quantitative evaluation of estrogen receptors in breast cancer.
    Rothmann C; Barshack I; Gil A; Goldberg I; Kopolovic J; Malik Z
    Histol Histopathol; 2000 Oct; 15(4):1051-7. PubMed ID: 11005229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coffee and black tea consumption and risk of breast cancer by estrogen and progesterone receptor status in a Swedish cohort.
    Larsson SC; Bergkvist L; Wolk A
    Cancer Causes Control; 2009 Dec; 20(10):2039-44. PubMed ID: 19597749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations and Technical Aspects of 16α-[18F]Fluoro-17β-Estradiol PET to Image the Estrogen Receptor In Vivo: The Groningen Experience.
    Venema CM; Apollonio G; Hospers GA; Schröder CP; Dierckx RA; de Vries EF; Glaudemans AW
    Clin Nucl Med; 2016 Nov; 41(11):844-851. PubMed ID: 27607175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.